Related Experiment Videos
Towards a more precise assay of sperm function in egg binding.
Nongnuj Tanphaichitr1, Jeff Haebe, Arthur Leader
1Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|June 14, 2003
Summary
A new assay using recombinant human zona pellucida 3 (rec hZP3) can assess sperm
Area of Science:
- Reproductive biology
- Infertility research
- Biochemistry
Background:
- Severe male factor infertility historically required donor sperm.
- Intracytoplasmic sperm injection (ICSI) with in vitro fertilization (IVF) expanded treatment options.
- Couples often prefer ICSI due to fertilization concerns, despite genetic risks.
Purpose of the Study:
- To evaluate recombinant human zona pellucida 3 (rec hZP3) as a surrogate for assessing sperm's egg binding capability.
- To offer an alternative to invasive methods for evaluating sperm function in male infertility.
Main Methods:
- Incubating sperm with rec hZP3 coated onto a microwell plate.
- Utilizing rec hZP3 as a substitute for human eggs, which are difficult to obtain.
- Producing sufficient quantities of rec hZP3 for assay development.
Main Results:
- Rec hZP3 can be effectively used as a surrogate for assessing sperm's ability to bind to the zona pellucida.
- An efficient assay can be developed using rec hZP3.
Conclusions:
- The rec hZP3 assay can identify infertile men whose sperm can bind to the zona pellucida.
- This assay can guide treatment choices, recommending standard IVF or intrauterine insemination for those with viable sperm binding.
- This approach offers a safer alternative to ICSI for certain male infertility cases.